Laurent Humeau is CSO at INOVIO PHARMACEUTICALS, INC. (INO). They have made 7 open-market trades across 1 company since 2019, most recently 2026-05-20.
CIK 0001770390
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $60K since 2019, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INO | 46,823 | $46K |
Shares reported on the most recent Form 4, priced at the 2026-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INO | SELL | 2021-08-09 | 2021-08-11 | $9.15 | $189K | -2.1% | -6.9% | -17.4% |
| INO | SELL | 2021-06-09 | 2021-06-11 | $9.07 | $187K | -4.6% | -10.4% | -7.8% |
| INO | SELL | 2020-11-10 | 2020-11-12 | $9.75 | $380K | -10.9% | -8.6% | +14.0% |
| INO | SELL | 2020-08-10 | 2020-08-12 | $19.06 | $742K | -9.1% | -25.2% | -14.6% |
| INO | SELL | 2020-06-22 | 2020-06-24 | $14.70 | $572K | -6.6% | -15.0% | -34.2% |
| INO | BUY | 2019-08-30 | 2019-09-04 | $2.22 | $10K | +26.3% | -1.4% | +19.5% |
| INO | BUY | 2019-06-05 | 2019-06-05 | $2.50 | $50K | +6.2% | +24.3% | -14.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.